Tuberculosis Drugs

 decision foresight.png

Global Tuberculosis Drugs Market Size, Share, Growth, Industry Trends and Forecast 2020-2030


Tuberculosis, also known as TB is a chronic infectious disease that affects the lungs and may also affect the other parts of the body. It is caused by a bacterial germ named Mycobacterium Tuberculosis. The major symptoms of TB include fever, loss of weight, night sweats, mucus containing blood while coughing or sneezing. Tuberculosis is a communicable disease which normally spreads in the air while coughing, sneezing, spitting, or speaking. The diagnosis of TB is performed through a microscopic examination, or chest x-rays. The growing prevalence of tuberculosis across the globe is the major factor driving the growth of the TB drugs market globally. The major focus of developing tuberculosis drugs is to shorten the duration of the treatment, and overcome certain challenges such as drug-resistant TB and drug-susceptible TB. The global tuberculosis drugs market is accounted approximate USD 1203.8 million in 2020 and it is expected to reach approximate USD 1960.9 million by 2030 with a CAGR of 5% during forecast period.  

Download Sample Copy of the Report to understand the structure of the complete report (Including Full TOC, Table & Figures) @ https://www.decisionforesight.com/request-sample/DFS020202

Market Dynamics and Factors:

Rising occurrence of multi-drug resistant (MDR) tuberculosis and drug susceptible (DS) tuberculosis cases, and growing R&D towards drug development are the major factors driving the growth of the tuberculosis drugs market globally. For instance, according to W.H.O in 2016, there were around 10.4 million cases of tuberculosis across the globe. Tuberculosis is the second most infectious killer disease claiming adult lives after HIV. The rising levels of air pollution along with increasing consumption of cigarettes are other major factors attributing to the prevalence of tuberculosis. This in turn is contributing towards the growth of the tuberculosis drugs market.  Additionally, collaborations among international organisations such as WHO, UNICEF, UNCTAD, and TB alliance are focussing on developing shorter treatment regimens to fight drug resistance. This is expected to drive the growth of the tuberculosis drugs market.  Apart from this, governments in high-risk nations are taking initiatives to counter the menace of TB and hence accelerating the market growth of TB drugs in the region. For instance, the Chinese government achieved a financial aid of 33 million USD through a partnership with Bill & Melinda Gates foundation to enhance detection and treatment of tuberculosis. However, high pricing of drugs and increasing drug recall are major factors restraining the growth of the tuberculosis drugs market. For instance, in 2018, Sandoz recalled a batch of its wrongly packed TB drugs in India. In 2016, a drug named Onecure manufactured by Novartis was recalled by Philippines Food & Drug Administration because of insufficient amount of rifampicin in the drug.

Market Segmentation:

  • Global Tuberculosis Drugs Market – By Disease Type

    • Active Tuberculosis

    • Latent Tuberculosis

  • Global Tuberculosis Drugs Market – By End-User

    • Hospital Pharmacy

    • Retail Pharmacy

    • Others

  • Global Tuberculosis Drugs Market – By Drug Class 

    • First-Line Anti-Tb Drugs

    • Second-Line Anti-Tb Drugs

    • Combination Drugs

  • Global Tuberculosis Drugs Market – By Geography

    • North America

      • U.S.

      • Canada

      • Mexico

    • Europe

      • U.K.

      • France

      • Germany

      • Italy

      • Rest of Europe

    • Asia-Pacific

      • Japan

      • China

      • India

      • Australia

      • Rest of Asia Pacific

    • ROW

      • Latin America

      • Middle East

      • Africa

New Business Strategies, Challenges & Policies are mentioned in Table of Content, Request TOC at @ https://www.decisionforesight.com/toc-request/DFS020202

Geographic Analysis:

North America is expected to dominate the global tuberculosis drugs market in terms of market share during the forecast period. Presence of a large number of drug manufacturers, growing geriatric population, and increasing cases of chronic tuberculosis are major factors driving the TB drugs market in the region. Europe is estimated to witness a significant growth in the global tuberculosis drugs market during the forecast period owing to a sizeable geriatric population. For instance, according to the U.K government, in 2017 around 57,9776 people in the U.K were above 90 years of age. The Asia Pacific region is estimated to be the fastest growing market for tuberculosis drugs during the forecast period. According to the W.H.O, around 45% of the population in South East Asia suffers from tuberculosis. The growing number of tuberculosis cases in South East Asian countries is driving the market in the APAC region. ROW market is expected to witness substantial tuberculosis drugs market growth during the forecast period.    

Competitive Scenario:

The key players operating in the global tuberculosis drugs market are –

Novartis AG, Pfizer Inc., Lupin, Johnson & Johnson, Otsuka Pharmaceuticals Co., Macleod Pharmaceuticals Ltd., Hoffman-La Roche Ltd., Sigma Pharmaceutical Pvt Ltd., Aventis Pharmaceuticals Ltd., Bayer Health Care, Cipla Limited, Merck & Co., Sanofi, Zydus Cadilla.

Connect to Analyst @ https://www.decisionforesight.com/speak-analyst/DFS020202 

How will this Market Intelligence Report Benefit You?

  1. The report offers statistical data in terms of value (US$) as well as Volume (units) till 2030.

  2. Exclusive insight into the key trends affecting the Global Tuberculosis Drugs industry, although key threats, opportunities and disruptive technologies that could shape the Global Tuberculosis Drugs Market supply and demand.

  3. The report tracks the leading market players that will shape and impact the Global Tuberculosis Drugs Market most.

  4. The data analysis present in the Global Tuberculosis Drugs Market report is based on the combination of both primary and secondary resources.

  5. The report helps you to understand the real effects of key market drivers or retainers on Global Tuberculosis Drugs Market business.

The 2021 Annual Global Tuberculosis Drugs Market offers:

  • 100+ charts exploring and analysing the Global Tuberculosis Drugs Market from critical angles including retail forecasts, consumer demand, production and more

  • 15+ profiles of top producing states, with highlights of market conditions and retail trends

  • Regulatory outlook, best practices, and future considerations for manufacturers and industry players seeking to meet consumer demand

  • Benchmark wholesale prices, market position, plus prices for raw materials involved in Global Tuberculosis Drugs Market type

Buy This Premium Research Report@ https://www.decisionforesight.com/checkout/DFS020202 

About Us:

Decision Foresight is a market research organization known for its reliable and genuine content, market estimation and the best analysis which is designed to deliver state-of-the-art quality syndicate reports to our customers. Apart from syndicate reports, you will find the best market insights, strategies that will help in taking better business decisions on subjects that may require you to develop and grow your business-like health, science, technology and many more. At Decision Foresight, we truly believe in disseminating the right piece of knowledge to a large section of the audience and cover the in-depth insights of market leaders across various verticals and horizontals.

Contact:

Email: sales@decisionforesight.com

For Latest Update Follow Us:

https://www.facebook.com/Decision-Foresight-110793387201935

https://twitter.com/DecisionFs

https://www.linkedin.com/company/decision-foresight/

Comments

Post a Comment

Popular posts from this blog

Digital Pathology

Image
  Global Digital Pathology Market Size, Share, Growth, Industry Trends and Forecast 2020-2030 Global Digital Pathology Market accounted USD 721.7 million in 2020 and is anticipated to reach USD 2281.7469 million by 2030, at a CAGR of 12.2% during the forecast period. It is an innovation predominantly committed to minimize laboratory expenses, increase operational efficiency, improving treatment decisions and patient care, and improved overall productivity. This technique incorporates the management, acquisition, sharing and interpretation of pathology information — which include slides and data — in a digital environment. Digital slides are produced when glass slides are apprehended with a scanning device, to deliver a high-resolution digital image that can be observed on a computer screen or mobile device. Virtual microscopy is a part of the market which enables to practice converting glass slides into digital slides that can be viewed, managed, shared and analyzed on a computer m...
Read more

Global Antisense And RNAi Therapeutics Market

Image
  Global Antisense And RNAi Therapeutics Market Size, Share, Growth, Industry Trends and Forecast 2020-2030 Antisense and RNAi therapeutics are therapeutic treatments having the potential to treat diseases such as chronic liver and cardiovascular diseases, and other rare diseases. Antisense RNAi was the largest technology segment in 2018 due to technological advancement in the healthcare sector. Antisense technology is a method that can stop protein production. Antisense technology can be used to design new therapeutics for certain new diseases. The principle behind is antisense nucleic acid sequence base pairs with complementary sense RNA strand and avoids from being translated into a protein. Based on the triggering of the RNA molecules this technology is segmented into siRNA and miRNA. Antisense and RNAi therapeutics services are applicable in the treatment of a wide range of diseases that target nucleic acid and affect the cell growth cycle. miRNA has the ability to restore gen...
Read more

Regenerative Therapies

Image
  Global Regenerative Therapies Market Size, Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts to 2030 The Global regenerative therapies market held USD 8.5 billion in 2020 and is to grow with a CAGR of 15.7% from 2020-2030. Regenerative medicine is medicine principle that focuses on the replacement of tissues, human cells and organs in order to restore normal functionality. Regenerative medicine aims to renew or replace cells in the damaged and unfitting tissue or organ of human beings. The body's own cells can be encouraged to cure, or a patient with laboratories-grown cells and tissues can be therapied. It can treat incurable chronic disorders and conditions such as Alzheimer's disease, Parkinson's disease, diabetes, cardiac illness, kidney failure, osteoporosis and injuries to the spinal cord, etc. Download Sample Copy of the Report to understand the structure of the complete report (Including Full TOC, Tabl...
Read more